Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2020;31(3):369-73
Peripheral Microangiopathy in Patients with Precapillary Pulmonary Hypertension: Correlation with Cardiac Function and Patients’ Functional Capacity. Study Design and Rationale
Authors Information

1. Fourth Department of Internal Medicine, Hippokration University Hospital, Medical School, Aristotle University of Thessaloniki, Greece
2.First Department of Cardiology, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
3. Department of Cardiology III - Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Muenster, Germany

Alexandra Arvanitaki , George Giannakoulas , Theodoros Dimitroulas 

References
  1. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015;46(4):903-75.
  2. Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 2014;115(1):165-75.
  3. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22(2):358-63.
  4. Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, Grimminger F, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 2009;54(1 Suppl):S10-9.
  5. Dimopoulos S, Tzanis G, Manetos C, Tasoulis A, Mpouchla A, Tseliou E, et al. Peripheral muscle microcirculatory alterations in patients with pulmonary arterial hypertension: a pilot study. Respir Care 2013;58(12):2134-41.
  6. Peled N, Bendayan D, Shitrit D, Fox B, Yehoshua L, Kramer MR. Peripheral endothelial dysfunction in patients with pulmonary arterial hypertension. Respir Med 2008;102(12):1791-6.
  7. Wolff B, Lodziewski S, Bollmann T, Opitz CF, Ewert R. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost. Am Heart J 2007;153(6):1088 e1-7.
  8. Lambova SN, Muller-Ladner U. Editorial: Nailfold Capillaroscopy in Rheumatology. Curr Rheumatol Rev 2018;14(1):2-4.
  9. Cutolo M, Melsens K, Herrick AL, Foeldvari I, Deschepper E, De Keyser F, et al. Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases. Rheumatology 2018;57(4):757-9.
  10. Cutolo M, Melsens K, Wijnant S, Ingegnoli F, Thevissen K, De Keyser F, et al. Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal. Autoimmun Rev 2018;17(4):344-52.
  11. Druyan A, Lidar M. Diagnosis of Systemic Sclerosis Based on Raynaud's Phenomenon, Capillaroscopy Findings, and Autoantibodies in the Absence of Sclerodactyly. Isr Med Assoc J 2018;20(10):658.
  12. Herrick AL, Murray A. The role of capillaroscopy and thermography in the assessment and management of Raynaud's phenomenon. Autoimmun Rev 2018;17(5):465-72.
  13. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013;65(11):2737-47.
  14. Smith V, Thevissen K, Trombetta AC, Pizzorni C, Ruaro B, Piette Y, et al. Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis. Microcirculation 2016;23(5):364-72.
  15. Paxton D, Pauling JD. Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review. Semin Arthritis Rheum 2018;48(3):482-94.
  16. Serne EH, Gans RO, ter Maaten JC, Tangelder GJ, Donker AJ, Stehouwer CD. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001;38(2):238-42.
  17. Edwards-Richards A, DeFreitas M, Katsoufis CP, Seeherunvong W, Sasaki N, Freundlich M, et al. Capillary rarefaction: an early marker of microvascular disease in young hemodialysis patients. Clin Kidney J 2014;7(6):569-74.
  18. Lisco G, Cicco G, Cignarelli A, Garruti G, Laviola L, Giorgino F. Computerized Video-Capillaroscopy Alteration Related to Diabetes Mellitus and Its Complications. Adv Exp Med Biol 2018;1072:363-8.
  19. Galiè N, Manes A, Farahani KV, Pelino F, Palazzini M, Negro L, et al. Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 2016;14(9):713-7.
  20. Arvanitaki A, Boutsikou M, Anthi A, Apostolopoulou S, Avgeropoulou A, Demerouti E, et al. Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE). Pulm Circ 2019;9(3):2045894019877157.
  21. Avouac J, Airo P, Meune C, Beretta L, Dieude P, Caramaschi P, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010;37(11):2290-8.
  22. Avouac J, Lepri G, Smith V, Toniolo E, Hurabielle C, Vallet A, et al. Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis. Semin Arthritis Rheum 2017;47(1):86-94.
  23. Sulli A, Pizzorni C, Smith V, Zampogna G, Ravera F, Cutolo M. Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheumatism 2012;64(3):821-5.
  24. Corrado A, Correale M, Mansueto N, Monaco I, Carriero A, Mele A, et al. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension. Microvasc Res 2017;114:46-51.
  25. Hofstee HM, Vonk Noordegraaf A, Voskuyl AE, Dijkmans BA, Postmus PE, Smulders YM, et al. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 2009;68(2):191-5.
  26. Laboratories ATSCoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Resp Crit Care Med 2002;166(1):111-7.
  27. Etehad Tavakol M, Fatemi A, Karbalaie A, Emrani Z, Erlandsson B-E. Nailfold Capillaroscopy in Rheumatic Diseases: Which Parameters Should Be Evaluated? BioMed Res Int 2015;2015:1-17.